Influence of silicone mammoplasty on the immunoendocrine status of female recipients

The article concerns a study of early influence of silicone breast implants on the development of autoimmune reactions and dynamics of prolactin and thyroid hormone levels in women after mammoplasty. At the present time, this issue remains relevant for several reasons: more than 20 million pairs of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. G. Zolotykh, A. N. Gvozdetsky, A. Ya. Kim, S. V. Lapin, L. R. Mikhailova, E. M. Starovoitova, T. V. Fedotkina, L. P. Churilov, Ye. Schoenfeld, P. K. Yablonsky
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2020
Materias:
Acceso en línea:https://doaj.org/article/e61a509312b941bbb8fcc904abfa4f5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e61a509312b941bbb8fcc904abfa4f5c
record_format dspace
spelling oai:doaj.org-article:e61a509312b941bbb8fcc904abfa4f5c2021-11-18T08:03:50ZInfluence of silicone mammoplasty on the immunoendocrine status of female recipients1563-06252313-741X10.15789/1563-0625-IOS-2006https://doaj.org/article/e61a509312b941bbb8fcc904abfa4f5c2020-12-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2006https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XThe article concerns a study of early influence of silicone breast implants on the development of autoimmune reactions and dynamics of prolactin and thyroid hormone levels in women after mammoplasty. At the present time, this issue remains relevant for several reasons: more than 20 million pairs of implants have been installed in the world and the number of their implantations is constantly growing. Despite relative safety of the silicone implants, some of them are periodically banned by regulatory bodies in various countries. At the same time, there is a growing number of controversial publications in the scientific literature, about potential adverse consequences of their use. Some authors suggest an association between the silicone implants and risk of developing autoimmune conditions, connective tissue disorders, and occasional malignancies. On the other hand, the journals are full of publications about the overall safe tolerance of such medical devices by the patients. These considerations served as a pre-requisite to our research. As part of this project, we have assayed serum levels of autoantibodies to ten antigens, as well as contents of prolactin and thyroid hormones by means of ELISA technique in 27 patients before, 3 and 6 months after aesthetic and reconstructive mammoplastics performed within a period of September 2018 to November 2019. As a result, it was found that 5 out of 27 patients exhibited changes in the autoimmunity spectrum and intensity after mammoplasty. In particular, the concentrations of autoantibodies to modified citrullinated vimentin and IgM autoantibodies to cardiolipin exceeded the normal level at 3 and 6 months. In addition, the initially high prolactin concentration in mammoplasty recipients dropped to normal ranges by 3 months after breast surgery, even after several-fold increased initial levels. As for thyroid hormones, there were no statistically significant changes in their dynamics. The increase of autoantibodies to various target antigens after mammoplasty was statistically significant and positively correlated with each other. This can be explained, for example, by dependence on the adjuvant effect of silicone, which is not associated with antigen specificity. However, it may generally stimulate the immune responses.V. G. ZolotykhA. N. GvozdetskyA. Ya. KimS. V. LapinL. R. MikhailovaE. M. StarovoitovaT. V. FedotkinaL. P. ChurilovYe. SchoenfeldP. K. YablonskySPb RAACIarticlemammoplastyautoimmunityprolactinsiliconeautoantibodiesadjuvantautoimmune-inflammatory syndrome induced by adjuvants (asia)Immunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 22, Iss 5, Pp 957-968 (2020)
institution DOAJ
collection DOAJ
language RU
topic mammoplasty
autoimmunity
prolactin
silicone
autoantibodies
adjuvant
autoimmune-inflammatory syndrome induced by adjuvants (asia)
Immunologic diseases. Allergy
RC581-607
spellingShingle mammoplasty
autoimmunity
prolactin
silicone
autoantibodies
adjuvant
autoimmune-inflammatory syndrome induced by adjuvants (asia)
Immunologic diseases. Allergy
RC581-607
V. G. Zolotykh
A. N. Gvozdetsky
A. Ya. Kim
S. V. Lapin
L. R. Mikhailova
E. M. Starovoitova
T. V. Fedotkina
L. P. Churilov
Ye. Schoenfeld
P. K. Yablonsky
Influence of silicone mammoplasty on the immunoendocrine status of female recipients
description The article concerns a study of early influence of silicone breast implants on the development of autoimmune reactions and dynamics of prolactin and thyroid hormone levels in women after mammoplasty. At the present time, this issue remains relevant for several reasons: more than 20 million pairs of implants have been installed in the world and the number of their implantations is constantly growing. Despite relative safety of the silicone implants, some of them are periodically banned by regulatory bodies in various countries. At the same time, there is a growing number of controversial publications in the scientific literature, about potential adverse consequences of their use. Some authors suggest an association between the silicone implants and risk of developing autoimmune conditions, connective tissue disorders, and occasional malignancies. On the other hand, the journals are full of publications about the overall safe tolerance of such medical devices by the patients. These considerations served as a pre-requisite to our research. As part of this project, we have assayed serum levels of autoantibodies to ten antigens, as well as contents of prolactin and thyroid hormones by means of ELISA technique in 27 patients before, 3 and 6 months after aesthetic and reconstructive mammoplastics performed within a period of September 2018 to November 2019. As a result, it was found that 5 out of 27 patients exhibited changes in the autoimmunity spectrum and intensity after mammoplasty. In particular, the concentrations of autoantibodies to modified citrullinated vimentin and IgM autoantibodies to cardiolipin exceeded the normal level at 3 and 6 months. In addition, the initially high prolactin concentration in mammoplasty recipients dropped to normal ranges by 3 months after breast surgery, even after several-fold increased initial levels. As for thyroid hormones, there were no statistically significant changes in their dynamics. The increase of autoantibodies to various target antigens after mammoplasty was statistically significant and positively correlated with each other. This can be explained, for example, by dependence on the adjuvant effect of silicone, which is not associated with antigen specificity. However, it may generally stimulate the immune responses.
format article
author V. G. Zolotykh
A. N. Gvozdetsky
A. Ya. Kim
S. V. Lapin
L. R. Mikhailova
E. M. Starovoitova
T. V. Fedotkina
L. P. Churilov
Ye. Schoenfeld
P. K. Yablonsky
author_facet V. G. Zolotykh
A. N. Gvozdetsky
A. Ya. Kim
S. V. Lapin
L. R. Mikhailova
E. M. Starovoitova
T. V. Fedotkina
L. P. Churilov
Ye. Schoenfeld
P. K. Yablonsky
author_sort V. G. Zolotykh
title Influence of silicone mammoplasty on the immunoendocrine status of female recipients
title_short Influence of silicone mammoplasty on the immunoendocrine status of female recipients
title_full Influence of silicone mammoplasty on the immunoendocrine status of female recipients
title_fullStr Influence of silicone mammoplasty on the immunoendocrine status of female recipients
title_full_unstemmed Influence of silicone mammoplasty on the immunoendocrine status of female recipients
title_sort influence of silicone mammoplasty on the immunoendocrine status of female recipients
publisher SPb RAACI
publishDate 2020
url https://doaj.org/article/e61a509312b941bbb8fcc904abfa4f5c
work_keys_str_mv AT vgzolotykh influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT angvozdetsky influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT ayakim influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT svlapin influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT lrmikhailova influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT emstarovoitova influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT tvfedotkina influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT lpchurilov influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT yeschoenfeld influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
AT pkyablonsky influenceofsiliconemammoplastyontheimmunoendocrinestatusoffemalerecipients
_version_ 1718422322942050304